Reata Pharmaceuticals RETA

Quarterly report 2023-Q1
added 05-10-2023

Reata Pharmaceuticals DPO Ratio 2011-2026 | RETA

Annual DPO Ratio Reata Pharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	5.6	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
5.6	5.6	5.6

DPO Ratio of other stocks in the Biotechnology industry

	Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
	AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
	I-Mab IMAB	2.24 K	-	-	$ 866 M	China
	Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
	Enlivex Therapeutics Ltd. ENLV	193	$ 0.77	-4.12 %	$ 35.2 M	Israel
	Exelixis EXEL	148	$ 48.16	4.22 %	$ 13.1 B	USA
	Fortress Biotech FBIO	400	$ 2.39	-0.42 %	$ 66.7 M	USA
	Compugen Ltd. CGEN	82.7	$ 2.9	1.4 %	$ 271 M	Israel
	Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
	ACADIA Pharmaceuticals ACAD	75.2	$ 22.4	-0.71 %	$ 3.71 B	USA
	Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
	Esperion Therapeutics ESPR	7.93 K	$ 3.14	-	$ 653 M	USA
	Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
	Gilead Sciences GILD	45.3	$ 131.33	-2.04 %	$ 163 B	USA
	AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
	Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
	Arcutis Biotherapeutics ARQT	133	$ 21.17	2.47 %	$ 2.69 B	USA
	Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
	Autolus Therapeutics plc AUTL	9.57	$ 1.57	-2.48 %	$ 418 M	Britain